Our findings revealed that drug-resistant colorectal cancer cells demonstrated upregulated expression of multiple components including the MIF-CXCR4 axis, Bcl-2/Bcl-XL proteins, and P-glycoprotein 29. This evidence concerns the gene BCL2 and colorectal cancer.